APA (7th ed.) Citation

Fukunaga, A., Kakei, Y., Murakami, S., Kan, Y., Masuda, K., Jinnin, M., . . . Hide, M. (2024). Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): A multicenter, open-label, randomized, parallel-group comparative study. Frontiers in immunology, 15, 1441478. https://doi.org/10.3389/fimmu.2024.1441478

Chicago Style (17th ed.) Citation

Fukunaga, Atsushi, et al. "Efficacy and Safety of Switching to Bilastine, an H1-antihistamine, in Patients with Refractory Chronic Spontaneous Urticaria (H1-SWITCH): A Multicenter, Open-label, Randomized, Parallel-group Comparative Study." Frontiers in Immunology 15 (2024): 1441478. https://doi.org/10.3389/fimmu.2024.1441478.

MLA (9th ed.) Citation

Fukunaga, Atsushi, et al. "Efficacy and Safety of Switching to Bilastine, an H1-antihistamine, in Patients with Refractory Chronic Spontaneous Urticaria (H1-SWITCH): A Multicenter, Open-label, Randomized, Parallel-group Comparative Study." Frontiers in Immunology, vol. 15, 2024, p. 1441478, https://doi.org/10.3389/fimmu.2024.1441478.